18 February 2020
The American Society of Clinical Oncology recently published a guideline for the management of male breast cancer* (and I was proud to serve on the guideline consensus panel).
Breast cancer in men accounts for approximately 1% of all breast cancer cases. Outcomes are known to be worse compared with those in women, in part due to later diagnosis. Unfortunately, men are often excluded from breast cancer clinical trials, so they are most often treated using the protocols approved for women. However, it is unclear if this is the best option in every situation. The US FDA has recently called to include men in studies of breast cancer treatment, even if anticipated enrollment is low. This is a necessary step so that progress can be made.
*If a copy of the full guideline is desired, please reach out: contact at drattai dot com
